NUV-422
- Generic Name
- NUV-422
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC
- Conditions
- Cancer of ProstateProstate CancerCastration Resistant Prostatic NeoplasmsProstatic CancerCancer of the ProstateProstate NeoplasmCastrate Resistant Prostate CancerCastration Resistant Prostatic Cancer
- Interventions
- First Posted Date
- 2022-01-13
- Last Posted Date
- 2022-08-05
- Lead Sponsor
- Nuvation Bio Inc.
- Registration Number
- NCT05191017
- Locations
- ๐บ๐ธ
Pennsylvania Cancer Specialists and Research Institute, Gettysburg, Pennsylvania, United States
๐บ๐ธGabrail Cancer Center Research, Canton, Ohio, United States
๐บ๐ธNEXT Virginia, Fairfax, Virginia, United States
Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC
- Conditions
- Advanced Breast CancerBreast TumorMetastatic Breast CancerBreast CarcinomaCancer of the BreastBreast CancerMalignant Tumor of BreastCancer of Breast
- Interventions
- First Posted Date
- 2022-01-13
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Nuvation Bio Inc.
- Registration Number
- NCT05191004
- Locations
- ๐บ๐ธ
Pennsylvania Cancer Specialists and Research Institute, Gettysburg, Pennsylvania, United States
๐บ๐ธPacific Cancer Medical Center, Inc., Anaheim, California, United States
๐บ๐ธCompassionate Cancer Care Research Inc., Fountain Valley, California, United States
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
- Conditions
- Cancer of BreastProstatic CancerCastrate Resistant Prostate CancerRecurrent GlioblastomaGlial Cell TumorsMalignant Tumor of BreastGlioma, MalignantGlioma, MixedProstate CancerCancer of the Prostate
- Interventions
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- Nuvation Bio Inc.
- Target Recruit Count
- 74
- Registration Number
- NCT04541225
- Locations
- ๐บ๐ธ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
๐บ๐ธCarolina BioOncology Institute, Huntersville, North Carolina, United States
๐บ๐ธTexas Oncology P.A. Austin, Austin, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.